BioCentury
ARTICLE | Company News

GlaxoSmithKline, Sepsicure L.L.C. deal

February 26, 2001 8:00 AM UTC

Sepsicure granted GSK development and marketing rights to GR 270773, a lipid emulsion that binds endotoxin. Preparations are underway to enter Phase II testing with the product to treat sepsis. Sepsic...